Show simple item record

The role of soluble guanylate cyclase in metabolism

dc.contributor.advisorPfeifer, Alexander
dc.contributor.authorNaumann, Jennifer
dc.date.accessioned2020-04-25T12:47:59Z
dc.date.available2020-04-25T12:47:59Z
dc.date.issued31.10.2018
dc.identifier.urihttp://hdl.handle.net/20.500.11811/7659
dc.description.abstractObesity is a worldwide health problem characterized by a chronic positive energy balance. The excess energy is stored primarily as lipids (TGs) in white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) utilizes energy to produce heat in response to cold exposure. BAT is a promising target for developing anti-obesity therapies. This thesis focusses on the role of soluble guanylate cyclase (sGC) in metabolism and identifies BATcentered therapies.
Analysis of sGCβ1 knockout mice revealed reduced BAT mass and less UCP1 expression in comparison to WT mice. Furthermore, differentiation and function of brown adipocytes was impaired in mice lacking the β1 subunit of sGC. Congruently, chronic stimulation of sGC with 3 μM BAY 41-8543 during differentiation of brown adipocytes (BAs) resulted in improved adipogenic (PPARg and aP2) and thermogenic marker (PGC-1a and UCP1) expression. Functionally, lipolysis, was also enhanced in BAs treated with BAY 41-8543.
Pharmacological stimulation of sGC during a high fat diet regime protects against weight gain. Stimulation of sGC increases function of BAs and energy consumption by UCP1 mediated thermogenesis. Importantly, BAY 41-8543 counteracts comorbidities of obesity, such as fatty liver and diabetes, even in already established obesity via increased energy expenditure. Notably, mice treated with the sGC stimulator exhibited reduced "whitening" of BAT and enhanced "browning" of WAT. In addition, sGC stimulation leads to increased expression of mitochondrial markers in muscle, which shows the overall effect of sGC stimulation. Stimulation of sGC results in increased lipid uptake and utilization by BAT, WATi, liver and muscle. Overall, sGC stimulation leads to reduced body weight gain, even in obese mice. Moreover, sGC stimulation improves metabolic phenotype in mice with diet-induced obesity (DIO), as well as on control diet (CD).
Therefore, sGC stimulators represent a novel pharmacological approach for the treatment of obesity and its comorbidities.
dc.language.isoeng
dc.rightsIn Copyright
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectMetabolismus
dc.subjectlösliche Guanylatzyklase
dc.subjectFettgewebe
dc.subjectÜbergewicht
dc.subjectDiabetes mellitus
dc.subjectmetabolism
dc.subjectsoluble guanylate cyclase
dc.subjectadipose
dc.subjecttissue
dc.subjectobesity
dc.subject.ddc500 Naturwissenschaften
dc.titleThe role of soluble guanylate cyclase in metabolism
dc.typeDissertation oder Habilitation
dc.publisher.nameUniversitäts- und Landesbibliothek Bonn
dc.publisher.locationBonn
dc.rights.accessRightsopenAccess
dc.identifier.urnhttps://nbn-resolving.org/urn:nbn:de:hbz:5n-52380
ulbbn.pubtypeErstveröffentlichung
ulbbn.birthnameEtzrodt
ulbbnediss.affiliation.nameRheinische Friedrich-Wilhelms-Universität Bonn
ulbbnediss.affiliation.locationBonn
ulbbnediss.thesis.levelDissertation
ulbbnediss.dissID5238
ulbbnediss.date.accepted26.01.2018
ulbbnediss.instituteMedizinische Fakultät / Institute : Institut für Pharmakologie und Toxikologie
ulbbnediss.fakultaetMathematisch-Naturwissenschaftliche Fakultät
dc.contributor.coRefereeMohr, Klaus


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

The following license files are associated with this item:

InCopyright